CHPA bullish on pending revision of O-T-C monograph policy
WASHINGTON — The stage is set for a regulatory change that will boost innovation by consumer health care products manufacturers, according to leaders of their association. The Food and Drug Administration’s O-T-C monograph system, which hasn’t been updated for over 45 years, is facing massive modernization efforts in the form of pending legislation in both
